Is NAD+ a peptide, or a coenzyme?

People search "is NAD+ a peptide?" all the time, and the honest answer is no. Nicotinamide adenine dinucleotide (NAD+) is a pyridine nucleotide coenzyme, not a string of amino acids. It ends up grouped with peptides for commercial reasons, because the same researchers buy both, but at the chemical level it belongs to an entirely different family.

For laboratory research only. NAD+ is sold strictly for in-vitro laboratory research. It has not been evaluated by the FDA, nothing here covers dosing, administration or use in people or animals, and no therapeutic claim is made.

What NAD+ actually is

NAD+ is an endogenous coenzyme and signaling molecule that sits at the heart of cellular metabolism. In its oxidized form it takes part in the electron-transfer reactions behind oxidative phosphorylation, glycolysis and mitochondrial energy production. It's always in equilibrium with its reduced form, NADH, and the NAD+/NADH ratio is one of the central variables researchers track.

Why people call it a "NAD peptide"

The phrase shows up everywhere, and it's a category mistake rather than a nickname. You can see how it happens: NAD⁺ comes from the same suppliers, gets studied in the same labs, and gets talked about in the same forums as research peptides, so the label sticks by association.

Structurally the two share nothing:

A peptide is a chain of amino acids held together by peptide bonds. NAD⁺ is a dinucleotide: two nucleotides, nicotinamide mononucleotide and adenosine monophosphate, linked through their phosphate groups. Not one amino acid appears anywhere in it, and there's no peptide bond. Calling it a peptide is about like calling a sugar a protein.

This isn't just pedantry, either. Because NAD⁺ isn't a peptide, it doesn't act like one in solution. Its stability profile is its own, and it's markedly pH-sensitive; see our guide on bacteriostatic water and solution stability, where NAD⁺ is the worked example.

Four forms that aren't interchangeable: NAD+, NADH, NADP+ and NADPH

Sources swap these around as if they were the same, and they aren't. Getting the distinction straight is the first thing that matters, because a protocol that calls for one and gets another is measuring something else entirely.

NAD+ and NADP+ are separated by a single phosphate group on the adenosine ribose, and that one group divides two mostly separate metabolic economies: the NAD+/NADH couple powers energy catabolism, while the NADP+/NADPH couple powers biosynthesis and antioxidant defense. That's precisely why cells hold them at very different ratios.

Where a cell's NAD+ comes from

The literature describes three routes, and knowing which one a given experiment is probing matters more than you'd expect.

• The salvage pathway. The dominant route in most mammalian cells. Nicotinamide freed by NAD+-consuming enzymes is recycled through nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting step, and this is where most pharmacological interest lands.
• The Preiss-Handler pathway. Starting from dietary nicotinic acid.
• De novo synthesis. From tryptophan by way of the kynurenine pathway. Real, but a minor contributor in most tissues.

Since the salvage pathway dominates, NAD+ levels in a cultured system come down largely to the balance between NAMPT activity and how hard the NAD+-consuming enzymes are working. That's why NAD+ concentration ends up as a dependent variable in most experiments rather than something you set.

NAD+ vs NMN vs NR

These three travel together constantly, and they're distinct molecules.

• NAD+ is the coenzyme itself.
• NMN (nicotinamide mononucleotide) is the immediate precursor, one enzymatic step away.
• NR (nicotinamide riboside) sits a step further back, converted first to NMN and then to NAD+.

For lab work the difference that counts is size and charge: NAD+ is a fairly large, heavily charged dinucleotide, which is exactly why the precursors draw interest as more tractable ways to raise intracellular NAD+ in a model. A study run on NR is not a study of NAD+, and the results don't transfer between them.

Why the age-related decline gets studied

One theme keeps returning in the literature: measured NAD+ levels fall with age across a range of tissues and model organisms. Proposed mechanisms include heavier consumption by PARPs reacting to accumulated DNA damage, changes in NAMPT expression, and shifts in the activity of other NAD+-consuming enzymes.

This is the observation driving most current interest in the molecule, and it's worth being precise about what it is and isn't. It's a reproducible finding in laboratory systems. It is not, by itself, evidence that any intervention reverses an outcome in a person. The leap from a measured biochemical decline to a clinical benefit is exactly the leap still under investigation, and we make no claim about it.

What researchers actually study

In biochemical and cellular systems, NAD+ is studied for its role in redox balance and as a substrate for NAD+-dependent enzymes, among them:

• Sirtuins, implicated in chromatin regulation
• Poly(ADP-ribose) polymerases (PARPs), implicated in DNA repair
• Cyclic ADP-ribose-generating enzymes, implicated in calcium signaling

Experimental outcomes hinge heavily on intracellular NAD+/NADH ratios, compartmentalization and the metabolic state of the model, so NAD+ serves widely as a reference compound in enzymology and metabolic research.

The MOTS-c connection

The two get studied together often, and the tie is mechanistic. AMPK (the cell's main energy sensor and the pathway examined most in MOTS-c research) and the NAD⁺/sirtuin axis are interlocking energy-sensing systems. A lab probing cellular energy regulation usually has cause to look at both. See what is MOTS-c peptide?.

Why NAD+ is fussier to handle than a peptide

Because NAD+ isn't a peptide, it doesn't behave like one, and the gaps are practical rather than academic.

pH runs the show. NAD+ breaks down under both acidic and alkaline conditions, and the oxidized and reduced forms react in opposite directions: NAD+ is the sturdier of the two in acid, NADH in base. A buffer picked for a peptide protocol won't automatically suit it.

Solutions don't keep. Aqueous NAD+ degrades measurably over time even under refrigeration, so it's made up close to the point of use rather than parked in solution for long stretches. Freeze-thaw cycling only compounds it.

Decay is often invisible. A peptide solution that's turned tends to give you a visual cue. NAD+ can shed a real share of its activity while looking exactly the same, which is why the prep date counts for more than appearance.

Our guide on bacteriostatic water and solution stability uses NAD+ as the worked example, since it's the compound in our catalog where solution handling makes the biggest difference to what you actually end up with.

What this page won't cover

A lot of the search interest around NAD+ is really about intravenous NAD+ therapy: clinic-administered infusions marketed for energy, recovery or aging. We don't supply that, we aren't a clinic, and we won't write about it as though we were.

The NAD+ we supply is a laboratory reference compound for in-vitro research. It isn't an infusion product, isn't a supplement, and isn't for use in humans or animals. If you're researching IV NAD+ therapy as a consumer, a regulated clinical provider is the right source of information and this page isn't it.

We also publish no dosing, reconstitution-for-use or administration guidance, for the same reason: quantity guidance aimed at a person would be at odds with what's actually being supplied.

Supply and handling

The NAD+ Kit ships with a batch-specific Certificate of Analysis that records identity and purity for the exact lot you receive, with purity measured by HPLC and identity confirmed by mass spectrometry. Every compound we supply is synthesized in our own UK laboratory rather than imported and repackaged, and each US lot of the NAD+ Kit is independently verified in a US laboratory before it ships. Like everything we supply, it's for in-vitro laboratory research only.

Given the stability profile above, the batch date on the certificate deserves more attention here than it would for a freeze-dried peptide. Recent certificates can be viewed in the COA library before you order.

To work out concentrations from a reconstituted vial, use the peptide calculator.

How the NAD+ Kit ships in the United States

For US laboratories the NAD+ Kit is dispatched cold-chain from the warehouse that serves the United States, with tracked delivery across the country next business day. It is priced in US dollars and payable by Visa, Mastercard or Apple Pay. Store it refrigerated at 2-8°C on arrival, not frozen. Because aqueous NAD+ is less stable than a plain peptide, prepare working solutions close to the point of use rather than holding them for long stretches, and treat the batch date on the certificate as a live variable rather than a formality.

Related reading

• New to all this? Start with what are research peptides?